ID
35198
Descripción
Study ID: 111364 Clinical Study ID: 111364 Study Title: A 28-Day, Polysomnographic and subjective assessment of Vestipitant (15mg/day) for the treatment of Primary Insomnia in adult Outpatients Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00992160 Clinicaltrials.gov Links: https://clinicaltrials.gov/ct2/show/NCT00992160 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Vestipitant, Placebo Trade Name: N/A Study Indication: Primary Insomnia, Sleep Disorders The purpouse of this form is to record the results of the subjects laboratory tests and should be filled out at Visit 1, 6 (liver tests only) , 8, EW, Day 7 Follow Up, Day 14 Follow Up. Laboratory tests are mandatory at Day 7 FU visit except where Day 7 FU follows Early Withdrawal Visit.
Link
https://clinicaltrials.gov/ct2/show/NCT00992160
Palabras clave
Versiones (2)
- 24/2/19 24/2/19 -
- 10/11/19 10/11/19 -
Titular de derechos de autor
GlaxoSmithKline
Subido en
24 de febrero de 2019
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Polysomnographic Assessment of Vestipitant for the Treatment of Primary Insomnia NCT00992160
Laboratory Tests
- StudyEvent: ODM
Similar models
Laboratory Tests
- StudyEvent: ODM
C2985720 (UMLS CUI [1,2])